Inactive Instrument

News Furiex Pharmaceuticals Inc

Equities

US36106P1012

End-of-day quote Nasdaq Other stock markets
- ^USD	-

2014	Actavis : Factbox - M&A frenzy transforming global pharma	RE
2014	Actavis : M&A frenzy in healthcare sector	RE

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Furiex Pharmaceuticals : Actavis Completes Acquisition of Furiex Pharmaceuticals	02/07/14	PR
Furiex Pharmaceuticals : Stockholders Approve Acquisition by Actavis; Ukrainian Antimonopoly Committee Clears Proposed Merger	01/07/14	BU
Furiex Pharmaceuticals : Reports First Quarter 2014 Financial Results	07/05/14	BU
Actavis : Factbox - M&A frenzy transforming global pharma	06/05/14	RE
Actavis : M&A frenzy in healthcare sector	06/05/14	RE
Furiex Pharmaceuticals : Ryan & Maniskas, LLP : Announces Investigation of Furiex Pharmaceuticals, Inc.	29/04/14	PR
Furiex Pharmaceuticals : Law Firm Kirby McInerney LLP Investigating Potential Claims on Behalf of Furiex Pharmaceuticals, Inc. Stockholders	28/04/14	BU
Furiex Pharmaceuticals : Stockholders Encouraged to Contact Securities Law Firm about Takeover	28/04/14	PR
Furiex Pharmaceuticals : Newman Ferrara LLP : Announces Investigation of Furiex Pharmaceuticals, Inc.	28/04/14	BU
Furiex Pharmaceuticals : Announces First Quarter 2014 Earnings Release and Conference Call	07/04/14	BU
Furiex Pharmaceuticals : Announces Acceptance to Late-Breaking Abstract Session at Digestive Disease Week 2014	03/04/14	BU
Furiex Pharmaceuticals : Confirms Takeda Will Present Additional Data from the EXAMINE Trial at the American College of Cardiology's 63rd Annual Scientific Session	27/03/14	PU
Furiex Pharmaceuticals : Confirms Takeda Will Present Additional Data from the EXAMINE Trial at the American College of Cardiology’s 63rd Annual Scientific Session	27/03/14	BU
Furiex Pharmaceuticals Inc : Furiex Pharmaceuticals Reports Fourth Quarter and Full-Year 2013 Financial Results	11/03/14	BU
Furiex Pharmaceuticals Inc : Furiex Pharmaceuticals Confirms Takeda's Submission of a New Drug Application for Trelagliptin Succinate (SYR-472) in Japan for the Treatment of Type 2 Diabetes	07/03/14	BU
Furiex Pharmaceuticals Inc : Furiex Pharmaceuticals Announces Fourth Quarter 2013 Earnings Release and Conference Call	10/02/14	BU
Furiex Pharmaceuticals Inc : Furiex Pharmaceuticals Announces Positive Top-Line Results of Two Pivotal Phase III Clinical Trials of Eluxadoline in Patients with IBS-d	04/02/14	BU
Furiex Pharmaceuticals Inc : Furiex Reports Third Quarter 2013 Financial Results	05/11/13	BU
Furiex Pharmaceuticals Inc : Furiex Pharmaceuticals Announces Priligy® Launch in the United Kingdom by Menarini	31/10/13	BU
Furiex Pharmaceuticals Inc : Furiex Pharmaceuticals Announces Management Changes	28/10/13	BU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Furiex Pharmaceuticals Inc

Equities

US36106P1012

Summary

Filters